168 related articles for article (PubMed ID: 18594270)
1. New antigenic targets in type 1 diabetes.
Wenzlau JM; Hutton JC; Davidson HW
Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):315-20. PubMed ID: 18594270
[TBL] [Abstract][Full Text] [Related]
2. Triple chimeric islet autoantigen IA2-ZnT8WR to facilitate islet autoantibody determination.
Yu L; Liu Y; Miao D; Wenzlau J; Davidson H; Hutton J; Eisenbarth GS
J Immunol Methods; 2010 Feb; 353(1-2):20-3. PubMed ID: 20035758
[TBL] [Abstract][Full Text] [Related]
3. SlC30A8 is a major target of humoral autoimmunity in type 1 diabetes and a predictive marker in prediabetes.
Wenzlau JM; Moua O; Sarkar SA; Yu L; Rewers M; Eisenbarth GS; Davidson HW; Hutton JC
Ann N Y Acad Sci; 2008 Dec; 1150():256-9. PubMed ID: 19120307
[TBL] [Abstract][Full Text] [Related]
4. Diabetes-linked zinc transporter ZnT8 is a homodimeric protein expressed by distinct rodent endocrine cell types in the pancreas and other glands.
Murgia C; Devirgiliis C; Mancini E; Donadel G; Zalewski P; Perozzi G
Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):431-9. PubMed ID: 19095428
[TBL] [Abstract][Full Text] [Related]
5. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes.
Wenzlau JM; Juhl K; Yu L; Moua O; Sarkar SA; Gottlieb P; Rewers M; Eisenbarth GS; Jensen J; Davidson HW; Hutton JC
Proc Natl Acad Sci U S A; 2007 Oct; 104(43):17040-5. PubMed ID: 17942684
[TBL] [Abstract][Full Text] [Related]
6. Different role of zinc transporter 8 between type 1 diabetes mellitus and type 2 diabetes mellitus.
Yi B; Huang G; Zhou Z
J Diabetes Investig; 2016 Jul; 7(4):459-65. PubMed ID: 27181765
[TBL] [Abstract][Full Text] [Related]
7. Relationship between ZnT8Ab, the SLC30A8 gene and disease progression in children with newly diagnosed type 1 diabetes.
Nielsen LB; Vaziri-Sani F; Pörksen S; Andersen ML; Svensson J; Bergholdt R; Pociot F; Hougaard P; de Beaufort C; Castaño L; Mortensen HB; Lernmark A; Hansen L;
Autoimmunity; 2011 Dec; 44(8):616-23. PubMed ID: 21604969
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune mechanisms in type 1 diabetes.
Knip M; Siljander H
Autoimmun Rev; 2008 Jul; 7(7):550-7. PubMed ID: 18625444
[TBL] [Abstract][Full Text] [Related]
9. Identification of a major humoral epitope in Slc30A8 (ZnT8).
Wenzlau JM; Moua O; Liu Y; Eisenbarth GS; Hutton JC; Davidson HW
Ann N Y Acad Sci; 2008 Dec; 1150():252-5. PubMed ID: 19120306
[TBL] [Abstract][Full Text] [Related]
10. Antigenicity and epitope specificity of ZnT8 autoantibodies in type 1 diabetes.
Skärstrand H; Lernmark A; Vaziri-Sani F
Scand J Immunol; 2013 Jan; 77(1):21-9. PubMed ID: 23126564
[TBL] [Abstract][Full Text] [Related]
11. ZnT8 and type 1 diabetes.
Kawasaki E
Endocr J; 2012; 59(7):531-7. PubMed ID: 22447136
[TBL] [Abstract][Full Text] [Related]
12. Current and Future Clinical Applications of Zinc Transporter-8 in Type 1 Diabetes Mellitus.
Yi B; Huang G; Zhou ZG
Chin Med J (Engl); 2015 Sep; 128(17):2387-94. PubMed ID: 26315089
[TBL] [Abstract][Full Text] [Related]
13. A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes.
Wenzlau JM; Liu Y; Yu L; Moua O; Fowler KT; Rangasamy S; Walters J; Eisenbarth GS; Davidson HW; Hutton JC
Diabetes; 2008 Oct; 57(10):2693-7. PubMed ID: 18591387
[TBL] [Abstract][Full Text] [Related]
14. Association between anti-ZnT8 autoantibody specificities and SLC30A8 Arg325Trp variant in Japanese patients with type 1 diabetes.
Kawasaki E; Uga M; Nakamura K; Kuriya G; Satoh T; Fujishima K; Ozaki M; Abiru N; Yamasaki H; Wenzlau JM; Davidson HW; Hutton JC; Eguchi K
Diabetologia; 2008 Dec; 51(12):2299-302. PubMed ID: 18850084
[TBL] [Abstract][Full Text] [Related]
15. The accelerator hypothesis and increasing incidence of type 1 diabetes.
Fourlanos S; Harrison LC; Colman PG
Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):321-5. PubMed ID: 18594271
[TBL] [Abstract][Full Text] [Related]
16. Mouse and man: multiple genes and multiple autoantigens in the aetiology of type I DM and related autoimmune disorders.
Gottlieb PA; Eisenbarth GS
J Autoimmun; 1996 Apr; 9(2):277-81. PubMed ID: 8738974
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk.
Achenbach P; Lampasona V; Landherr U; Koczwara K; Krause S; Grallert H; Winkler C; Pflüger M; Illig T; Bonifacio E; Ziegler AG
Diabetologia; 2009 Sep; 52(9):1881-8. PubMed ID: 19590848
[TBL] [Abstract][Full Text] [Related]
18. Development of a luciferase-based system for the detection of ZnT8 autoantibodies.
Ustinova J; Zusinaite E; Utt M; Metsküla K; Reimand K; Huchaiah V; Merits A; Uibo R
J Immunol Methods; 2014 Mar; 405():67-73. PubMed ID: 24462542
[TBL] [Abstract][Full Text] [Related]
19. Characterization of zinc transporter 8 (ZnT8) antibodies in autoimmune diabetic patients from Argentinian population using monomeric, homodimeric, and heterodimeric ZnT8 antigen variants.
Faccinetti NI; Guerra LL; Penas Steinhardt A; Iacono RF; Frechtel GD; Trifone L; Poskus E; Trabucchi A; Valdez SN
Eur J Endocrinol; 2016 Feb; 174(2):157-65. PubMed ID: 26567119
[TBL] [Abstract][Full Text] [Related]
20. What has zinc transporter 8 autoimmunity taught us about type 1 diabetes?
Williams CL; Long AE
Diabetologia; 2019 Nov; 62(11):1969-1976. PubMed ID: 31444530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
